NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · IEX Real-Time Price · USD
2.980
+0.120 (4.20%)
At close: Jul 19, 2024, 4:00 PM
3.050
+0.070 (2.35%)
After-hours: Jul 20, 2024, 12:57 PM EDT
NeurAxis Revenue
NeurAxis had revenue of $2.30M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $646.64K. In the year 2023, NeurAxis had annual revenue of $2.46M.
Revenue (ttm)
$2.30M
Revenue Growth
-15.37%
P/S Ratio
8.61
Revenue / Employee
$121,136
Employees
19
Market Cap
19.81M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.46M | -224.69K | -8.37% |
Dec 31, 2022 | 2.68M | -36.55K | -1.34% |
Dec 31, 2021 | 2.72M | 541.06K | 24.82% |
Dec 31, 2020 | 2.18M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionNRXS News
- 6 weeks ago - NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure - GlobeNewsWire
- 2 months ago - NeurAxis Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 - GlobeNewsWire
- 2 months ago - NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024 - GlobeNewsWire
- 3 months ago - NeurAxis Announces New Medical Policy Coverage in North Dakota - GlobeNewsWire
- 3 months ago - NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results - GlobeNewsWire
- 3 months ago - NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024 - GlobeNewsWire
- 4 months ago - NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry - GlobeNewsWire